OR56A7P

Across TCGA pan-cancer cohorts, OR56A7P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated OR56A7P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher OR56A7P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR56A7P expression acts as an unfavorable survival marker.

LIHC, KIRC, and STAD are the cancer types where OR56A7P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	II,III,IV	0.145	0.719	<.001	72	view →
KIRC	DFS	Tertile	IV	0.140	0.625	<.001	42	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	27	view →
THCA	DFS	Tertile	All	0.579	0.915	.013	27	view →
READ	DFS	Tertile	II,III,IV	0.336	0.816	.032	27	view →
BLCA	DFS	Tertile	All	0.229	0.503	.045	18	view →
COAD	OS	Tertile	III,IV	0.151	0.699	<.001	18	view →
UCEC	DFS	Tertile	IV	0.181	0.705	.009	18	view →
KIRP	OS	Tertile	All	0.599	0.903	.009	18	view →
LGG	DFS	Tertile	All	0.570	0.831	.004	12	view →
BRCA	DFS	Tertile	II,III,IV	0.444	0.521	.046	6	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

OR56A7P–LIHC (OS)

Open the LIHC breakdown →